North America Insulin Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Insulin Market – By Type

1.3.2 North America Insulin Market – By Country

2. North America Insulin Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Insulin Market – Market Landscape

4.1 Overview

4.2 North America PEST Analysis

4.2.1 Expert Opinion

5. North America Insulin Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Incidence of Diabetes

5.1.2 Rapid Technological Developments in Insulin Delivery Devices by Major Players

5.2 Market Restraints

5.2.1 Risks Associated with Insulin Delivery Devices

5.3 Market Opportunities

5.3.1 Insufficient Competition from Biosimilars

5.4 Future Trends

5.4.1 Regeneration of Diabetic Pancreas with Advanced Transplants

5.5 Impact Analysis

6. Insulin Market– North America Analysis

6.1 North America Insulin Market Revenue Forecast and Analysis

7. North America Insulin Market Analysis – By Type

7.1 Overview

7.2 North America Insulin Market Revenue Share, by Type (2021 and 2028)

7.3 Long Acting Insulin

7.3.1 Overview

7.3.2 Long Acting Insulin: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Levemir

7.3.2.1.1 Overview

7.3.2.1.2 Levemir: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Lantus

7.3.2.2.1 Overview

7.3.2.2.2 Lantus: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Basaglar

7.3.2.3.1 Overview

7.3.2.3.2 Basaglar: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.4 Tresiba

7.3.2.4.1 Overview

7.3.2.4.2 Tresiba: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Rapid Acting Insulins

7.4.1 Overview

7.4.2 Rapid Acting Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1 Novolog

7.4.2.1.1 Overview

7.4.2.1.2 Novolog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.2 Humalog

7.4.2.2.1 Overview

7.4.2.2.2 Humalog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.3 Admelog

7.4.2.3.1 Overview

7.4.2.3.2 Admelog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.4 Others

7.4.2.4.1 Overview

7.4.2.4.2 Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Short Acting Insulins and Traditional Human Insulins

7.5.1 Overview

7.5.2 Short Acting Insulins and Traditional Human Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1 Novolin R

7.5.2.1.1 Overview

7.5.2.1.2 Novolin R: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.2 Humulin R

7.5.2.2.1 Overview

7.5.2.2.2 Humulin R: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.3 Insuman

7.5.2.3.1 Overview

7.5.2.3.2 Insuman: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.4 Others

7.5.2.4.1 Overview

7.5.2.4.2 Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Concentrated Insulins and Combination Insulins

7.6.1 Overview

7.6.2 Concentrated Insulins and Combination Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.1 NovoMix

7.6.2.1.1 Overview

7.6.2.1.2 NovoMix: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.2 Ryzodeg

7.6.2.2.1 Overview

7.6.2.2.2 Ryzodeg: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.3 Xultophy

7.6.2.3.1 Overview

7.6.2.3.2 Xultophy: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.4 Soliqua/Suliqua

7.6.2.4.1 Overview

7.6.2.4.2 Soliqua/Suliqua: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Biosimilar Insulins

7.7.1 Overview

7.7.2 Biosimilar Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.7.2.1 Insulin Glargine

7.7.2.1.1 Overview

7.7.2.1.2 Insulin Glargine: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.7.2.2 Human Insulin

7.7.2.2.1 Overview

7.7.2.2.2 Human Insulin: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.8 Glucagon-like peptide-1 (GLP-1)

7.8.1 Overview

7.8.2 Glucagon-like peptide-1 (GLP-1): Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.9 Pens and Needles

7.9.1 Overview

7.9.2 Pens and Needles: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

7.10 Others

7.10.1 Overview

7.10.2 Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

8. North America Insulin Market – Country Analysis

8.1 Overview

8.1.1 North America: Insulin Market, by Country, 2021 & 2028 (%)

8.1.1.1 US: Global Insulin market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.1.1 US: Insulin market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.1.2 US: Insulin Market, By Type, 2019–2028 (US$ Million)

8.1.1.1.2.1 US: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.1.1.1.2.2 US: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.1.1.1.2.3 US: Insulin Market, By Short-acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.1.1.2.4 US: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.1.1.2.5 US: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.1.1.2 Canada: Insulin market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.2.1 Canada: Insulin market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.2.2 Canada: Insulin Market , By Type, 2019–2028 (US$ Million)

8.1.1.2.2.1 Canada: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.1.1.2.2.2 Canada: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.1.1.2.2.3 Canada: Insulin Market, By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.1.2.2.4 Canada: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.1.2.2.5 Canada: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

8.1.1.3 Mexico: Insulin market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.3.1 Mexico: Insulin market – Revenue and Forecast to 2028 (US$ Million)

8.1.1.3.2 Mexico: Insulin Market, By Type, 2019–2028 (US$ Million)

8.1.1.3.2.1 Mexico: Insulin Market, By Long Acting Insulin, 2019–2028 (US$ Million)

8.1.1.3.2.2 Mexico: Insulin Market, By Rapid Acting Insulin, 2019–2028 (US$ Million)

8.1.1.3.2.3 Mexico: Insulin Market, By Short acting Insulins and Traditional Human Insulins, 2019–2028 (US$ Million)

8.1.1.3.2.4 Mexico: Insulin Market, By Concentrated Insulins and Combination Insulins, 2019–2028 (US$ Million)

8.1.1.3.2.5 Mexico: Insulin Market, By Biosimilar Insulins, 2019–2028 (US$ Million)

9. North America Insulin Market–Industry Landscape

9.1 Overview

9.2 Organic Developments

9.2.1 Overview

9.3 Inorganic Developments

9.3.1 Overview

10. Company Profile

10.1 Eli Lilly and Company

10.1.1 Key Facts

10.1.2 Business Description

10.1.3 Products and Services

10.1.4 Financial Overview

10.1.5 SWOT Analysis

10.1.6 Key Developments

10.2 Novo Nordisk A/S

10.2.1 Key Facts

10.2.2 Business Description

10.2.3 Products and Services

10.2.4 Financial Overview

10.2.5 SWOT Analysis

10.2.6 Key Developments

10.3 Biocon

10.3.1 Key Facts

10.3.2 Business Description

10.3.3 Products and Services

10.3.4 Financial Overview

10.3.5 SWOT Analysis

10.3.6 Key Developments

10.4 Wockhardt

10.4.1 Key Facts

10.4.2 Business Description

10.4.3 Products and Services

10.4.4 Financial Overview

10.4.5 SWOT Analysis

10.4.6 Key Developments

10.5 GlaxoSmithKline plc.

10.5.1 Key Facts

10.5.2 Business Description

10.5.3 Products and Services

10.5.4 Financial Overview

10.5.5 SWOT Analysis

10.5.6 Key Developments

10.6 Sanofi

10.6.1 Key Facts

10.6.2 Business Description

10.6.3 Products and Services

10.6.4 Financial Overview

10.6.5 SWOT Analysis

10.6.6 Key Developments

10.7 Pfizer Inc.

10.7.1 Key Facts

10.7.2 Business Description

10.7.3 Products and Services

10.7.4 Financial Overview

10.7.5 SWOT Analysis

10.7.6 Key Developments

10.8 Merck & Co., Inc.

10.8.1 Key Facts

10.8.2 Business Description

10.8.3 Products and Services

10.8.4 Financial Overview

10.8.5 SWOT Analysis

10.8.6 Key Developments

10.9 Tonghua Dongbao Pharmaceutical Co., Ltd.

10.9.1 Key Facts

10.9.2 Business Description

10.9.3 Products and Services

10.9.4 Financial Overview

10.9.5 SWOT Analysis

10.9.6 Key Developments

11. Appendix

11.1 About The Insight Partners

11.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Insulin Market, Revenue and Forecast, 2019–2028 (US$ Million)

Table 2. US: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 3. US: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 4. US: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 5. US: Insulin Market, By Short-acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 6. US: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 7. US: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 8. Canada: Insulin Market , By Type – Revenue and Forecast to 2028 (US$ Million)

Table 9. Canada: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 10. Canada: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 11. Canada: Insulin Market, By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 12. Canada: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 13. Canada: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 14. Mexico: Insulin Market, By Type – Revenue and Forecast to 2028 (US$ Million)

Table 15. Mexico: Insulin Market, By Long Acting Insulin – Revenue and forecast to 2028 (US$ Million)

Table 16. Mexico: Insulin Market, By Rapid Acting Insulin - Revenue and Forecast to 2028 (US$ Million)

Table 17. Mexico: Insulin Market, By Short acting Insulins and Traditional Human Insulins - Revenue and Forecast to 2028 (US$ Million)

Table 18. Mexico: Insulin Market, By Concentrated Insulins and Combination Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 19. Mexico: Insulin Market, By Biosimilar Insulins- Revenue and Forecast to 2028 (US$ Million)

Table 20. Organic Developments in the Insulin Market

Table 21. Inorganic Developments in the Insulin Market

Table 22. Glossary of Terms, North America Insulin Market

LIST OF FIGURES

Figure 1. North America Insulin Market Segmentation

Figure 2. North America Insulin Market Segmentation, By Country

Figure 3. North America Insulin Market Overview

Figure 4. The Long Acting Insulin Segment Held Largest Share of Type in the Insulin Market

Figure 5. US Is Expected to Show Remarkable Growth During the Forecast Period

Figure 7. North America PEST Analysis

Figure 8. Expert Opinion

Figure 9. North America Insulin Market Impact Analysis of Drivers and Restraints

Figure 10. North America Insulin Market– Revenue Forecast and Analysis

Figure 11. North America Insulin Market Revenue Share, by Type (2021 and 2028)

Figure 12. North America Long Acting Insulin: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. North America Levemir: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. North America Lantus: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. North America Basaglar: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. North America Tresiba: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. North America Rapid Acting Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. North America Novolog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. North America Humalog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. North America Admelog: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. North America Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. North America Short Acting Insulins and Traditional Human Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. North America Novolin R: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. North America Humulin R: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. North America Insuman: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. North America Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. North America Concentrated Insulins and Combination Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. North America NovoMix: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. North America Ryzodeg: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. North America Xultophy: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. North America Soliqua/Suliqua: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. North America Biosimilar Insulins: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. North America Insulin Glargine: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. North America Human Insulin: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. North America Glucagon-like peptide-1 (GLP-1): Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. North America Pens and Needles: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. North America Others: Insulin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38. North America Insulin Market, by Key Country – Revenue (2021) (US$ Million)

Figure 39. North America: Insulin Market, by Country, 2021 & 2028 (%)

Figure 40. US: Insulin market – Revenue and Forecast to 2028 (US$ Million)

Figure 41. Canada: Insulin market – Revenue and Forecast to 2028 (US$ Million)

Figure 42. Mexico: Insulin market – Revenue and Forecast to 2028 (US$ Million)